World Journal of
Pharmaceutical and Life Sciences

A REVIEW ON NOVEL THERAPEUTIC OPTIONS FOR THE TREATMENT OF TUBERCULOSIS IN THE COMMUNITY

Thanakanti Bhargavi*, A. Bharath Kumar, S. Kavya, Thota Srimannarayana, Shaik Mohammad Sohail, D. Jothieswari

ABSTRACT

Tuberculosis is a common cause of death and illness across the world. To reduce the worldwide impact of tuberculosis, early identification of the infection and early identification of therapeutic resistance is necessary. Although authorised diagnostic procedures like as culture, direct microscopy, bio-molecular assays, and whole genome sequencing are available, their general usage is typically limited due to prices, local resources, time restrictions, and operator efficiency. The susceptibility pattern of the isolate found determines which medication regimen should be used. The advancements in the treatment of tuberculosis lead to the development of novel therapeutic protocols including in the near future. By strengthening existing diagnostic and treating procedures, promoting prevention measures, increasing government commitment and greater funding, and accelerating research and innovation, the End-TB Strategy launched by WHO intends to significantly reduce the trouble of Tuberculosis on its way to global extinction. A variety of newer medications and therapeutic techniques are useful for the treatment of tuberculosis in the community.

[Full Text Article]   [Download Certificate]